jlagasse

Author's posts

Infection control measures in Hong Kong have protected healthcare workers from COVID-19 coronavirus

Standard infection-control practices have been effective, including vigilant hand hygiene, wearing surgical masks and using protective equipment.

Telehealth a target for venture capitalists as its potential to diagnose coronavirus grows

Faster internet speeds, better tech and avoiding other potentially sick patients is pushing investors to pump money into the remote care space.

CMS offers new guidance regarding protective masks and screening, treatment of COVID-19 coronavirus

The proactive steps are part of the White House Task Force’s efforts to ensure proper supply and containment of the disease.

Best practices emerging for protecting healthcare workers from coronavirus

Mitigation strategies will become increasingly important as healthcare organizations look to protect their staff members from contracting the disease.

Credit stress continues to rise in healthcare sector as maturities loom, social risks rise

Healthcare companies on Moody’s list of lower-rated companies have about $41.6 billion of outstanding debt, a 28% increase in the past year.

Healthcare private equity had a record year with deal values close to $79 billion

The increasing size of healthcare deal values stemmed primarily from large buyouts, as the average deal size rose roughly 25%.

Dartmouth-Hitchcock Health says COVID-19 coronavirus is contained in New Hampshire

The health system said it has followed all of the proper procedures, and no new cases of the coronavirus have been detected so far in the state.

Despite red tape, most pediatricians are supportive of national vaccination program

The program has increased vaccination rates, decreased vaccine-preventable illnesses and reduced social and racial disparities.

Coronavirus risk factors prompt public health concerns, though it’s not as deadly as SARS

If there’s one silver lining, it’s that while the coronavirus has had a significant global impact, it’s not as deadly as SARS or MERS.

Drug prices rose three times faster than inflation over the last decade, even after discounts

Inflation-adjusted list prices increased by 159% from 2007 to 2018, while net prices increased 60%.